Taraxacum alleviates ulcerative colitis, accompanied by the modulation of gut microbiota and restoration of intestinal barrier integrity
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1778487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Chunsheng Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Taizhou People's Hospital, Nanjing Medical University, Taizhou, Jiangsu, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Taraxacum, Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Previous studies have shown that Taraxacum (TM) possesses strong antioxidant, anti-inflammatory, and antibacterial activities, but the mechanism regarding how TM attenuates IBD requires further exploration. This study evaluated the therapeutic effects of TM (0.15, 0.75, and 1.5 g/kg) on ulcerative colitis induced by Dextran Sulfate Sodium (DSS) in mice.
Results
After 14 days of treatment following colitis induction, the herbal extract alleviated body weight loss and pathological abnormalities in the mice. In comparison to the DSS group, the 1.5 g/kg The TM therapy group had markedly elevated levels of colonic T-SOD, T-AOC, and GSH-Px (P < 0.05), alongside a substantial decrease in MDA content (P < 0.05) and inflammatory cytokines (IL-2, IL-6, IFN-g, TNF-a) (P < 0.05). Furthermore, TM markedly elevated the concentrations of volatile fatty acids (acetate, propionate, isobutyrate, and butyrate) in the cecal contents (P < 0.05). The 0.75 and 1.5 g/kg TM groups also elevated the expression of Claudin-1, Occludin, and ZO-1 (P < 0.05), whereas the DSS group showed reduced expression of these mucosal barrier proteins. Concerning gut microbiota, at the Phylum level, the relative abundance of Firmicutes was markedly elevated in the 1.5 g/kg TM groups (P < 0.05), Bacteroidetes exhibited a considerable reduction (P < 0.05); TM alleviated colitis concurrent with the restoration of beneficial Muribaculaceae and reduction of harmful Desulfovibrio . Notably, Desulfovibrio was inhibited more effectively than in 5-ASA, a change associated with intestinal homeostasis.
Conclusion
TM alleviated colitis is correlated with enhancing antioxidant capacity, reducing inflammation, restoringbarrier integrity, and modulating the gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Taizhou People's Hospital, Nanjing Medical University, Taizhou, Jiangsu, China.
- Medical Department, Yangzhou University School of Medicine, Yangzhou, Jiangsu, China.
Zitieren
APA
Fu, C., Chen, Z., Xu, C., Hua, H., & Ye, J. (2026). Taraxacum alleviates ulcerative colitis, accompanied by the modulation of gut microbiota and restoration of intestinal barrier integrity. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1778487
Vancouver
Fu C, Chen Z, Xu C, Hua H, Ye J. Taraxacum alleviates ulcerative colitis, accompanied by the modulation of gut microbiota and restoration of intestinal barrier integrity. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1778487
BibTeX
@article{Fu2026,
author = {Fu, Chunsheng and Chen, Zheyu and Xu, Chensen and Hua, Huilian and Ye, Jun},
title = {Taraxacum alleviates ulcerative colitis, accompanied by the modulation of gut microbiota and restoration of intestinal barrier integrity},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1778487}
}
EUVIMED